GeneDx Holdings Corp (WGS)
78.71
+6.64
(+9.21%)
USD |
NASDAQ |
Nov 22, 16:00
78.78
+0.07
(+0.09%)
After-Hours: 20:00
GeneDx Holdings Revenue (Quarterly): 76.87M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 76.87M |
| June 30, 2024 | 70.51M |
| March 31, 2024 | 62.42M |
| December 31, 2023 | 57.42M |
| September 30, 2023 | 53.30M |
| June 30, 2023 | 48.71M |
| March 31, 2023 | 43.14M |
| December 31, 2022 | 61.35M |
| September 30, 2022 | 83.23M |
| Date | Value |
|---|---|
| June 30, 2022 | 36.17M |
| March 31, 2022 | 53.94M |
| December 31, 2021 | 57.80M |
| September 30, 2021 | 43.18M |
| June 30, 2021 | 47.02M |
| March 31, 2021 | 64.20M |
| December 31, 2020 | 63.96M |
| September 30, 2020 | 38.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
36.17M
Minimum
Jun 2022
83.23M
Maximum
Sep 2022
56.58M
Average
57.42M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
| Spok Holdings Inc | 34.87M |
| Ontrak Inc | 2.569M |
| DarioHealth Corp | 7.423M |
| National Research Corp | 35.82M |
| FOXO Technologies Inc | 1.196M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.312M |
| Total Expenses (Quarterly) | 84.65M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 2.098B |
| Gross Profit Margin (Quarterly) | 62.22% |
| Profit Margin (Quarterly) | -10.81% |
| Earnings Yield | -3.95% |
| Normalized Earnings Yield | -3.428 |